Position in AGIO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$46,340,665
+$7,381,566 QoQ
Shares Held
1,248,738
+8.4% QoQ
Ownership
2.09%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 4%
None 3%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. AGIO ranks #31 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in AGIO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,340,665 | 1,248,738 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $38,959,099 | 1,151,614 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $27,338,160 | 1,004,341 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $40,991,006 | 1,021,201 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $36,788,651 | 1,106,093 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $36,978,736 | 1,262,073 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $43,673,074 | 1,329,065 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $69,407,788 | 1,562,183 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $94,695,182 | 2,196,085 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $75,397,035 | 2,578,558 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $57,829,932 | 2,596,764 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $60,857,551 | 2,458,891 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $64,111,323 | 2,263,818 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $48,038,330 | 2,091,351 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $46,418,455 | 1,653,079 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $41,808,839 | 1,478,389 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $29,777,788 | 1,343,157 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $29,419,031 | 1,010,616 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $23,843,930 | 725,401 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $24,943,982 | 540,498 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $15,638,730 | 283,773 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $14,986,237 | 290,206 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $12,598,674 | 290,761 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $11,396,210 | 325,606 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $18,211,330 | 340,526 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $13,664,980 | 385,146 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||